CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
We have now added a new section called the "Assay History List" to the "At A Gla...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...